Login / Signup

Survival benefit of adjuvant transcatheter arterial chemoembolization for patients with hepatocellular carcinoma after anatomical hepatectomy.

Tai-Wei YeDong-Dong WangWen-Feng LuYa-Ming XieFei-Qi XuTian-Wei FuKang-Jun ZhangSi-Yu LiuGui-Lin XieJian ChengKai JiangZun-Qiang XiaoWei-Feng YaoGuo-Liang ShenJun-Wei LiuDong-Sheng HuangCheng-Wu ZhangLei Liang
Published in: Expert review of gastroenterology & hepatology (2023)
Patients with HCC after AH can benefit from postoperative adjuvant TACE. Therefore, adjuvant TACE should be considered for patients with a high risk of recurrence.
Keyphrases
  • early stage
  • free survival
  • liver metastases